Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Earnshaw

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Transfusion|July 21, 2021
Clinical and economic impacts of large volume delayed sampling and pathogen reduction technology platelet processing strategies in the United StatesStephanie Earnshaw, Hadi Beyhaghi, Cheryl McDade, et al.
Infectious Diseases and Therapy|June 24, 2018
Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in CanadaMichele Wilson, Matt Wasserman, Taj Jadavi, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2018
Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Cost-Effectiveness AnalysisJamie Jarmul, Mark J Pletcher, Kristen Hassmiller Lich, et al.
Clinical Therapeutics|April 21, 2015
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised PatientsRosemary Barnes, Stephanie Earnshaw, Raoul Herbrecht, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Transfusion|July 21, 2021
Clinical and economic impacts of large volume delayed sampling and pathogen reduction technology platelet processing strategies in the United StatesStephanie Earnshaw, Hadi Beyhaghi, Cheryl McDade, et al.
Infectious Diseases and Therapy|June 24, 2018
Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in CanadaMichele Wilson, Matt Wasserman, Taj Jadavi, et al.
Circulation. Cardiovascular Quality and Outcomes|April 14, 2018
Cardiovascular Genetic Risk Testing for Targeting Statin Therapy in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Cost-Effectiveness AnalysisJamie Jarmul, Mark J Pletcher, Kristen Hassmiller Lich, et al.
Clinical Therapeutics|April 21, 2015
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised PatientsRosemary Barnes, Stephanie Earnshaw, Raoul Herbrecht, et al.
Pageof 2